CVS Health Corporation (CVS) stock forecast & analysis
86.46
NYSE · USD
Up: +1.26, +1.5%
86.93Up: +0.47, +0.5%
1 analysis
- Open
- 85.25
- Previous close
- 85.20
- Day range
- 85.25 – 87.15
- 52-week range
- 69.51 – 110.68
- Volume (shares)
- 10.45M
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 1.28B
- P/E ratio
- 22.81
- Dividend yield
- 3.08%
- Beta
- 0.58
- Market cap
- 110.58B
Market Scanner’s AI analysis of CVS Health Corporation (CVS), updated October 2026: CVS Health's strategic shift to value-based care and Medicare plan adjustments were central to recent analyses, alongside pharmaceutical distribution agreements.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of CVS Health Corporation (CVS) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
CVS Health's strategic shift to value-based care and Medicare plan adjustments were central to recent analyses, alongside pharmaceutical distribution agreements.
Recent analyses examined CVS Health's strategic pivot towards value-based care and its 2027 Medicare plans, which may present opportunities amidst competitor reductions. The reports also covered the extension of key pharmaceutical distribution agreements and noted technical indicators suggesting downward momentum.
CVS news & sentiment
News coverage highlighted CVS Health's strategic shift to value-based care and its Medicare plans, alongside extended distribution agreements. Some news commentary questioned the stock's remaining downside risk.
CVS technical picture
CVS Health's closing price traded below its 50-day and 200-day simple moving averages, with short-term momentum readings also indicating downward pressure. Momentum indicators like RSI and MFI approached oversold territory, while MACD confirmed bearish momentum within the Bollinger Band range.
Fundamentals
The analysis covered CVS Health's revenue growth and significant quarterly earnings growth, alongside its profit and operating margins. Valuation metrics such as P/E ratios and dividend yield were also discussed, as was the company's market capitalization and return on equity.
Factors discussed — upside
- Quarterly earnings growth YOY was 188.8%.
- Competitors reducing Medicare Advantage plans may create opportunities.
- Extension of pharmaceutical distribution agreements through 2032.
Factors discussed — risks
- Stock price below 50-day and 200-day simple moving averages.
- RSI approaching oversold territory.
- MFI in oversold range.
- MACD confirming bearish momentum.
- Questions raised about remaining downside risk for the stock.
- Value-based care strategy
- Medicare Advantage plans
- Pharmaceutical distribution agreements
- Technical indicators
Summary updated .
CVS technical indicators
Common technical indicators for CVS, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 94.90 | Price below |
| 10-day exponential moving average | 87.36 | Price below |
| Relative strength index (14-day) | 36.96 | Neutral |
| MACD line (12/26/9) | -2.6888 | Below its signal line |
| Bollinger bands (20-day, 2σ) | 82.08 – 98.53 | Price inside the bands |
Analyses
Recent CVS.US analyses are locked — sign in to read them or generate a fresh one.
Frequently asked questions
- What is the bull case for CVS Health Corporation?
- The bull case for CVS Health centered on its significant quarterly earnings growth and strategic positioning in value-based care, potentially benefiting from competitors' reduced Medicare Advantage plans. The extension of key pharmaceutical distribution agreements through 2032 was also noted as a positive development.
- What are the risks for CVS Health Corporation?
- Risks discussed for CVS Health included the stock trading below key moving averages, with technical indicators like the RSI and MFI approaching or in oversold territory, and MACD confirming bearish momentum. Questions were also raised about the stock's remaining downside risk.
- Is CVS Health Corporation bullish or bearish?
- Recent AI analyses of CVS Health Corporation examined factors on both sides. Discussed upside: The bull case for CVS Health centered on its significant quarterly earnings growth and strategic positioning in value-based care, potentially benefiting from competitors' reduced Medicare Advantage plans. The extension of key pharmaceutical distribution agreements through 2032 was also noted as a positive development. Discussed risks: Risks discussed for CVS Health included the stock trading below key moving averages, with technical indicators like the RSI and MFI approaching or in oversold territory, and MACD confirming bearish momentum. Questions were also raised about the stock's remaining downside risk. These are descriptive observations, not a recommendation.
- What is the latest sentiment on CVS Health Corporation?
- News coverage highlighted CVS Health's strategic shift to value-based care and its Medicare plans, alongside extended distribution agreements. Some news commentary questioned the stock's remaining downside risk.
- How does Market Scanner analyse CVS Health Corporation?
- Every analysis of CVS Health Corporation runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
- Bundles used
- gemini-low-v2
Run a fresh CVS.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.